Recce’s R327 found effective against E.coli during clinical trial

Recce Pharmaceuticals Ltd has found that its R327 drugs is effective in treating Escherichia coli during…

Imugene expands study for bile tract cancer patients

Imugene will be expanding its trial to treat gastrointestinal cancers - including bile tract cancer -…